Industry leaders share how the pandemic affected their business

We asked some of our friends how COVID-19 has affected them and their organisations. In particular the implications for Risk-Based Quality Management (RBQM), Central, Remote and Site monitoring. The stories are insightful, interesting and predict the future for clinical trials. Many thanks to everyone kind enough to give up their valuable time to share thoughts and insights.